🇺🇸 FDA
Patent

US 7244844

Reference standard for characterization of rosuvastatin

granted A61PA61P3/06

Quick answer

US patent 7244844 (Reference standard for characterization of rosuvastatin) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P3/06